ICD-10-CM Billable Code

D3A.02

Benign carcinoid tumors of the appendix, large intestine, and rectum

Clinical Classification Guidelines

Medical Intelligence & Overview

Benign carcinoid tumors are slow-growing, non-cancerous growths that originate from neuroendocrine cells within the appendix, large intestine, or rectum. These tumors are generally not aggressive and often discovered incidentally during examinations or surgeries for unrelated issues. While considered benign, they warrant appropriate monitoring and medical attention due to their potential to grow or, in rare cases, transform.

Causes & Symptoms

Clinical Causes: Exact causes of benign carcinoid tumors are largely unknown. Genetic factors may play a role, with certain inherited conditions increasing risk. Certain environmental factors and lifestyle choices might contribute, though evidence is limited. Precise mechanisms involve abnormal growth of neuroendocrine cells, but triggers remain under investigation.

Key Symptoms: Often asymptomatic, especially in early stages. Possible abdominal pain or discomfort. Changes in bowel habits like diarrhea or constipation. Rectal bleeding or bleeding around the tumor site. Nausea or a feeling of fullness. A palpable mass in the abdomen or pelvis in some cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves several steps:

Treatment Protocols: Treatment options depend on tumor size, location, and presence of symptoms:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.02 a billable ICD-10 code?
Yes, D3A.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.02?
Clinical documentation must specify the nature of Benign carcinoid tumors of the appendix, large intestine, and rectum and any associated comorbidities for accurate reporting.

Cite this Clinical Reference